Myeloproliferative Neoplasm Whole Blood

<h2>Myeloproliferative Neoplasm Whole Blood for Research</h2>
Myeloproliferative neoplasms (MPN) are a group of blood cancers, including polycythemia vera, essential thrombocythemia, and myelofibrosis, most frequently driven by JAK2, CALR, or MPL mutations. Sanguine collects fresh whole blood from IRB-consented donors with a clinically confirmed MPN diagnosis for hematologic oncology research.
<h3>Product Features</h3>
<ul><li>Fresh whole blood from clinically diagnosed MPN donors</li><li>Custom anticoagulants and collection tubes available</li><li>Same-day collection and shipment</li><li>Research Use Only (RUO)</li></ul>
<h3>De-identified Donor Data</h3>
<ul><li>Physician-confirmed diagnosis, including MPN subtype and JAK2/CALR/MPL status where available</li><li>Demographics: age, sex assigned at birth, ethnicity</li><li>Relevant medical and treatment history</li></ul>
<h3>Applications</h3>
<ul><li>JAK2/CALR/MPL mutation research</li><li>Myeloproliferative pathway and biomarker studies</li><li>Gene expression and transcriptomic analysis</li><li>JAK inhibitor therapy response research</li></ul>
<h3>Also Available</h3>
Looking for polycythemia vera specifically? See our <a href=”https://sanguinebio.com/product/polycythemia-vera-whole-blood/”>Polycythemia Vera Whole Blood</a> product.
<h3>Compliance and Quality</h3>
<ul><li>IRB-approved protocols and electronic informed consent</li><li>HIPAA-compliant donor data handling</li></ul>
<h3>Ordering and Customization</h3>
MPN whole blood is available in standard and custom volumes. Email <a href=”mailto:learnmore@sanguinebio.com”>learnmore@sanguinebio.com</a> for international orders or documentation requirements.